| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |